IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$10.6M
3
+$7.73M
4
SAGE
Sage Therapeutics
SAGE
+$6.1M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$5.3M

Top Sells

1
+$12.7M
2
+$11.3M
3
+$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.76M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
-60,000
77
– –
0
78
– –
-3,500
79
– –
-29
80
– –
-31,694
81
– –
-21,192
82
– –
0
83
– –
-25
84
– –
-45,516
85
– –
0
86
– –
0
87
– –
-86,865
88
– –
-410
89
– –
-86,035
90
– –
-61,500
91
– –
-125,000
92
– –
-61,433
93
– –
-14,770
94
– –
0
95
– –
0
96
– –
-100,000
97
– –
0
98
– –
-51,606
99
– –
-329
100
– –
-7,064
2 3
4
5 6